Clinical Trial Update: Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating magnesium supplementation in patients with major depressive disorder treated with SSRIs has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Magnesium supplementation (magnesium)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: MDD | Phase 2 | Status: COMPLETED